National Health Investors, Inc. (NHI)

Sector:
REAL ESTATE
Industry:
REAL ESTATE INVESTMENT TRUSTS
SIC:
REAL ESTATE INVESTMENT TRUSTS
CEO:
D. Eric Mendelsohn
Employees:
20
222 ROBERT ROSE DRIVE, MURFREESBORO, TN 37129
6158909100

National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.

Data derived from most recent annual or quarterly report
Market Cap 2.536 Billion Shares Outstanding45.851 Million Avg 30-day Volume 321.51 Thousand
P/E Ratio41.1366 Dividend Yield5.9396 EPS1.63
Price to Revenue10.0864 Debt to Equity0.7817 EBITDA171.56 Million
Price to Book Value1.991 Operating Margin28.306399999999996 Enterprise Value3.853 Billion
Current Ratio1.714 EPS Growth-0.572 Quick Ratio1.714
1 Yr BETA 0.3793 52-week High/Low 66.11 / 47.86 Profit Margin24.4112
Operating Cash Flow Growth-12.0982 Altman Z-Score1.6404 Free Cash Flow to Firm 597.065 Million
Earnings Report2022-11-07
View SEC Filings from NHI instead.

View recent insider trading info

Funds Holding NHI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NHI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-09-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
  • 8-K: filed on 2022-08-09:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-08-08:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-09:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-09:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-04-18:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-04:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    1.5 Thousand total shares from 1 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    18.3 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PASCOE KEVIN CARLTON CHIEF INVESTMENT OFFICER

    • Officer
    161,228 2022-08-26 2

    ADAMS ROBERT G

    • Director
    659,990 2022-08-15 3

    COLDEN TRACY M J

    • Director
    0 2022-06-01 2

    ADAMS W ANDREW

    • Director
    1,135,846 2022-02-25 1

    SWAFFORD CHARLOTTE A

    • Director
    150,185 2022-02-25 1

    WEBB ROBERT T

    • Director
    155,339 2022-02-25 2

    MCCABE ROBERT A JR

    • Director
    68,251 2022-02-25 1

    JOBE JAMES R

    • Director
    64,479 2022-02-25 1

    MENDELSOHN D. ERIC CEO AND PRESIDENT

    • Officer
    421,258 2022-02-25 1

    GAINES KRISTIN SALLEE CHIEF CREDIT OFFICER

    • Officer
    242,944 2022-02-25 1

    SPAID JOHN L CFO/EVP FINANCE

    • Officer
    192,449 2022-02-25 1

    TRAVIS DAVID L SVP/CHIEF ACCOUNTING OFFICER

    • Officer
    60,834 2022-02-25 1

    REEL RONALD V CHIEF ACCOUNTING OFFICER

    • Officer
    19,937 2020-02-21 0

    HOPKINS ROGER R CHIEF ACCOUNTING OFFICER

    • Officer
    46,000 2019-02-21 0

    HUTCHENS JAMES JUSTIN CEO AND PRESIDENT

    • Officer
    • Director
    67,419 2015-03-31 0

    WELCH TED H

    • Director
    90,310 2013-02-25 0

    DENBESTEN KENNETH D SENIOR VP, FINANCE/SECRETARY

    • Officer
    138,192 2008-04-23 0

    LAROCHE RICHARD F JR

    • Director
    562,949 2008-03-10 0

    DANIEL DONALD K SENIOR V.P. & CONTROLLER

    • Officer
    153,452 2006-12-31 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    PASCOE KEVIN CARLTON - Officer CHIEF INVESTMENT OFFICER

    2022-08-30 09:14:27 -0400 2022-08-26 M 18,333 $53.41 a 48,958 direct -0.6069 -0.0455 0.0 1 -2.6855 4

    PASCOE KEVIN CARLTON - Officer CHIEF INVESTMENT OFFICER

    2022-08-30 09:14:27 -0400 2022-08-26 F 16,065 $67.10 d 32,893 direct -0.6069 -0.0455 0.0 1 -2.6855 4

    PASCOE KEVIN CARLTON - Officer CHIEF INVESTMENT OFFICER

    2022-08-30 09:14:27 -0400 2022-08-26 M 18,333 d 0 direct

    ADAMS ROBERT G - Director investment advisor

    2022-08-16 11:27:54 -0400 2022-08-15 P 1,500 $65.93 a 85,411 indirect -0.1068 0.5339 -12.3875 2.3646 8 -14.2792 30

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    NATL HEALTH INVESTORS INC NHI 2022-09-30 22:15:04 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 21:45:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 21:15:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 20:45:04 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 20:15:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 19:45:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 19:15:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 18:45:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 18:15:04 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 17:45:04 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 17:15:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 16:45:04 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 16:15:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 15:45:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 15:15:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 14:45:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 14:15:03 UTC 2.6558 0.4142 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 13:45:03 UTC 2.6455 0.4245 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 13:15:03 UTC 2.6455 0.4245 850000
    NATL HEALTH INVESTORS INC NHI 2022-09-30 12:45:03 UTC 2.6455 0.4245 850000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund NHI -25550.0 shares, $-1548585.5 2022-06-30 N-PORT
    VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND NHI -79192.0 shares, $-4799827.12 2022-06-30 N-PORT
    GLENMEDE FUND INC- Quantitative U.S. Total Market Equity Portfolio NHI -3300.0 shares, $-213972.0 2022-07-31 N-PORT
    GLENMEDE FUND INC- Quantitative U.S. Long/Short Equity Portfolio NHI -11000.0 shares, $-713240.0 2022-07-31 N-PORT
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund NHI -2266.0 shares, $-146927.44 2022-07-31 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    representative Virginia Foxx republican House Filing 2022-06-28 2022-06-28 JT P $15,001-$50,000

    Elevate your investments